What this study adds:
- We analysed the adverse reactions associated with sugammadex in
VigiBase.
- Recurrence of neuromuscular
blockade and cardiorespiratory issues were the most frequent adverse
reactions reported in some lethal cases.
- Patients should be carefully monitored after sugammadex
administration, especially at age 0−17 years, > 65 years,
or with cardiac diseases.